Skip to main content
Clinical Trials/NL-OMON47184
NL-OMON47184
Completed
N/A

Development and validation of an algorithm for an ultra low-power miniaturized device with accelerometry, electrocardiography and electromyography based tonic seizure detection. - EpiSense trial

Epilepsiecentrum Kempenhaeghe0 sites30 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Epilepsiecentrum Kempenhaeghe
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Epilepsiecentrum Kempenhaeghe

Eligibility Criteria

Inclusion Criteria

  • Patients who meet all of the following criteria are eligible for this study:
  • \- Currently residing at Providentia (long stay facilities of Kempenhaeghe)
  • \- Over 18 years of age
  • \- Nightly tonic and/or tonic\-clonic seizures
  • \- Minimal seizure frequency: 1/week
  • \- Informed consent form signed by legal representatives

Exclusion Criteria

  • Subjects meeting one or more of the following criteria cannot be selected:
  • \- History of heart failure, significant heart disease or, obstructive sleep apnea
  • \- Drugs or pacemakers that significantly influence heart rate (for example beta\-blockers)
  • \- Inability to comply with the test procedure
  • \- Inability to tolerate the used electrodes

Outcomes

Primary Outcomes

Not specified

Similar Trials